BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27210479)

  • 1. A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Prokai L; Ottinger MA
    Horm Behav; 2016 Jul; 83():39-44. PubMed ID: 27210479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Ottinger MA; Prokai L
    Horm Behav; 2018 Feb; 98():16-21. PubMed ID: 29183688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.
    Yan W; Wu J; Song B; Luo Q; Xu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):879-886. PubMed ID: 30879099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
    Amtul Z; Wang L; Westaway D; Rozmahel RF
    Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.
    Prokai L; Nguyen V; Szarka S; Garg P; Sabnis G; Bimonte-Nelson HA; McLaughlin KJ; Talboom JS; Conrad CD; Shughrue PJ; Gould TD; Brodie A; Merchenthaler I; Koulen P; Prokai-Tatrai K
    Sci Transl Med; 2015 Jul; 7(297):297ra113. PubMed ID: 26203081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice.
    Levin-Allerhand JA; Lominska CE; Wang J; Smith JD
    J Alzheimers Dis; 2002 Dec; 4(6):449-57. PubMed ID: 12515896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy.
    Prokai-Tatrai K; Nguyen V; Prokai L
    ACS Chem Neurosci; 2018 Nov; 9(11):2528-2533. PubMed ID: 29843514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease.
    Green PS; Bales K; Paul S; Bu G
    Endocrinology; 2005 Jun; 146(6):2774-81. PubMed ID: 15731362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.
    Petanceska SS; Nagy V; Frail D; Gandy S
    Neurology; 2000 Jun; 54(12):2212-7. PubMed ID: 10881241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid.
    Hruska Z; Dohanich GP
    Horm Behav; 2007 Sep; 52(3):297-306. PubMed ID: 17583706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.
    Feng HL; Dang HZ; Fan H; Chen XP; Rao YX; Ren Y; Yang JD; Shi J; Wang PW; Tian JZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):734-741. PubMed ID: 27466310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan/17β-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1/ACE2 and AT1/AT2 ratio.
    Abdelkader NF; Abd El-Latif AM; Khattab MM
    Life Sci; 2020 Mar; 245():117388. PubMed ID: 32007576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.